NPPA to Re-Examine Iohexol Injection Price Challenged by JB Chemicals Farhat Nasim31 Dec 2024 6:47 PM ISTNew Delhi: In a respite to Mumbai-based JB Chemicals and Pharmaceuticals, the Department of Pharmaceuticals (DoP) has directed the National...
Karnataka HC Stays Action Against Pharma Firms Producing Nutraceuticals in Drug Facilities Farhat Nasim30 Dec 2024 5:43 PM ISTBengaluru: In a significant move for the pharmaceutical sector, the Karnataka High Court has directed the government to abstain from taking...
Submit justification for dose assumption and animal toxicity data: CDSCO Panel Tells Lupin on Rizatriptan nasal spray Dr. Divya Colin29 Dec 2024 6:00 PM ISTNew Delhi: Regarding the proposed bioavailability study protocol for Rizatriptan nasal spray (2.5 mg/spray, 5 mg/spray, 7.5 mg/spray), the Subject...
Exemed Pharmaceutical Gets CDSCO Panel Nod To Manufacture, Market Amlodipine, Bisoprolol FDC Dr. Divya Colin28 Dec 2024 6:00 PM ISTNew Delhi: Considering the request for bioequivalence (BE) and Phase III clinical trial (CT) waiver, the Subject Expert Committee (SEC) functional...
AstraZeneca Gets CDSCO Panel Nod To study Anti-Cancer Drug Rilvegostomig Dr. Divya Colin27 Dec 2024 6:00 PM ISTNew Delhi: Pharmaceutical major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Standard Control...
Pfizer Gets CDSCO Panel nod to Import Abrocitinib tablets for moderate to severe atopic dermatitis Dr. Divya Colin26 Dec 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Pfizer Products India has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Parliamentary Panel Slams NPPA for 50% Price Hike, Demands Answers Farhat Nasim25 Dec 2024 5:02 PM ISTNew Delhi: The Parliamentary Standing Committee on Chemicals and Fertilisers has slammed the National Pharmaceutical Pricing Authority (NPPA) for...
No Bail for Pharma Firm Owner Accused of Producing Spurious Drugs Farhat Nasim24 Dec 2024 6:03 PM ISTThe court noted that granting bail would encourage other drug manufacturers to produce and market spurious drugs for easy money.
Only 5.9% Spurious Drug Cases Resolved: Parliamentary Panel Slams Govt Farhat Nasim23 Dec 2024 5:17 PM ISTNew Delhi: Take stringent action in a time bound manner for exemplary punishments for spurious/adulterated drugs, the Parliamentary Standing...
Indian Pharma Market to Hit Rs 2.38 Lakh Crore by 2025: Pharmarack Report Farhat Nasim22 Dec 2024 12:00 PM ISTNew Delhi: The Indian Pharma Market (IPM) is set to grow by 8.2% in 2025, reaching Rs 2.38 lakh crore under a realistic scenario, according to...
NPPA Fixes Retail Price of 65 New Drugs, Ceiling Price of 20 Formulations, Details Farhat Nasim21 Dec 2024 3:02 PM ISTNew Delhi: Through recent notifications, the National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers,...
NPPA Turns to Patent Office for Clarity on Drug Price Exemptions, Defers Intas, Biological E's Applications Farhat Nasim20 Dec 2024 6:11 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has sought expertise from the Indian Patent Office to assist in making decisions...
